XML 41 R30.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Sale of Product Line - Narrative (Details)
3 Months Ended
Mar. 31, 2024
USD ($)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]  
Proceeds from the sale of product line $ 5,000,000
Gain on sale of product line 7,580,000
MiMedx Group, Inc.  
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]  
Proceeds from the sale of product line 5,000,000.0
Minimum | MiMedx Group, Inc.  
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]  
Revenue sharing payments 3,000,000.0
Maximum | MiMedx Group, Inc.  
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]  
Revenue sharing payments 7,000,000.0
Transaction | MiMedx Group, Inc.  
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]  
Amount minimum revenue share payments receivable 3,000,000.0
Amount minimum revenue share payments receivable current 300,000
Amount minimum revenue share payments receivable non-current 2,700,000
Transaction | Minimum | MiMedx Group, Inc.  
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]  
Revenue sharing payments 3,000,000.0
Variable consideration 3,000,000.0
Transaction | Maximum | MiMedx Group, Inc.  
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]  
Revenue sharing payments 7,000,000.0
Variable consideration 7,000,000.0
Transaction | Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member] | MiMedx Group, Inc.  
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]  
Net carrying value 800,000
Carrying value 0
Proceeds from the sale of product line 5,000,000.0
Consideration determined 8,400,000
Gain on sale of product line $ 7,600,000